TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28965797

Group type: EXPERIMENTAL
Intervention: LopiGLIK®
Number of subjects: 359

Group type: COMPARATOR
Intervention: Armolipid Plus®
Number of subjects: 359
Study: 26087573

Group type: EXPERIMENTAL
Intervention: Titanium abutment
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Gold-hue titanium abutment
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Zirconia abutment
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 47
Study: 23714755

Group type: EXPERIMENTAL
Intervention: Fast-absorbing catgut (FAC) sutures
Number of subjects: 98

Group type: COMPARATOR
Intervention: Nylon (NYL) sutures
Number of subjects: 98
Study: 21093060

Group type: EXPERIMENTAL
Intervention: Real TMS (LF-TMS)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 34
Study: 19101755

Group type: EXPERIMENTAL
Intervention: 500,000 IU loading dose
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 500,000 IU loading dose + 50,000 IU/month
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 50,000 IU/month
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (baseline 25OHD > 50 nmol/L)
Number of subjects: 63
Study: 16757922

Group type: EXPERIMENTAL
Intervention: Active food challenge
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 15093843

Group type: EXPERIMENTAL
Intervention: i.v. CaCl(2) pre-treatment
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo pre-treatment
Number of subjects: 78
Study: 11952848

Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b and ribavirin for 6 months
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b and ribavirin for 12 months
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b and ribavirin for both durations
Number of subjects: 61
Study: 9848042

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) (approximately 10 micrograms/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Oral hydromorphone (60 micrograms/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Both OTFC and hydromorphone
Number of subjects: 14
Study: 8011819

Group type: EXPERIMENTAL
Intervention: Meglumine antimonate for 20 days
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Meglumine antimonate for 10 days
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Meglumine antimonate for 10 days plus alternate-day injections of interferon-gamma
Number of subjects: 66
Study: 2638182

Group type: EXPERIMENTAL
Intervention: 0.3% triclosan toothpaste
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 0.5% triclosan toothpaste with PVM/MA copolymer
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 0.5% triclosan toothpaste without PVM/MA copolymer
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine rinse
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Commercial fluoride toothpaste
Number of subjects: 14

Group type: COMPARATOR
Intervention: Water
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control paste
Number of subjects: 14
Study: 125578

Group type: EXPERIMENTAL
Intervention: Lithium carbonate and haloperidol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: COMPARATOR
Intervention: Lithium carbonate
Number of subjects: 6
Study: 30799485

Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive-behavioral therapy (T-CBT)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 397
Study: 29282005

Group type: EXPERIMENTAL
Intervention: Urine LAM testing
Number of subjects: 187

Group type: COMPARATOR
Intervention: Sputum production
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Sputum-scarce patients
Number of subjects: 187
Study: 26086603

Group type: EXPERIMENTAL
Intervention: High loading dose of Rosuvastatin before PCI (n = 264)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Standard treatment (n = 264)
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: High loading dose of Rosuvastatin before PCI
Number of subjects: 528

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 528
Study: 22961230

Group type: EXPERIMENTAL
Intervention: Text-based smoking cessation support
Number of subjects: 1000
Study: 21622634

Group type: EXPERIMENTAL
Intervention: Bacteriostatic saline solution containing 0.9% benzyl alcohol before lidocaine infiltration
Number of subjects: 45

Group type: COMPARATOR
Intervention: Lidocaine injection without prior saline injection
Number of subjects: 45
Study: 19323394

Group type: EXPERIMENTAL
Intervention: Palodent matrix system
Number of subjects: 101

Group type: COMPARATOR
Intervention: Circumferential matrix system
Number of subjects: 101
Study: 16427545

Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (100 mg/kg before skin incision followed by 1 g/hour continuous infusion until chest closure, 10 g in cardiopulmonary bypass circuit)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid
Number of subjects: 100
Study: 15262625

Group type: EXPERIMENTAL
Intervention: Optical displacement during pointing task with delayed visual feedback
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Measurement of head-shoulder posture while viewing optically displaced field
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: First-trial adaptation
Number of subjects: 24
Study: 10971859

Group type: EXPERIMENTAL
Intervention: EPD (immunotherapy)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 8790757

Group type: EXPERIMENTAL
Intervention: Vestibular training (VT) with drug therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medication alone (Control)
Number of subjects: 0
Study: 1617762

Group type: EXPERIMENTAL
Intervention: Intensive physical exercise and low-fat diet (minimum 2 hr/wk group training, 20 min/d home exercise)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 113
Study: 6439700

Group type: EXPERIMENTAL
Intervention: Fast neutron radiation therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional photon radiation therapy
Number of subjects: 40
Study: 31678306

Group type: EXPERIMENTAL
Intervention: Adiponectin
Number of subjects: 1968

Group type: EXPERIMENTAL
Intervention: Leptin
Number of subjects: 1968

Group type: EXPERIMENTAL
Intervention: Resistin
Number of subjects: 1968
Study: 31349791

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cooperative High-Intensity Interval Training (C-HIIT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sedentary condition
Number of subjects: 32
Study: 29117929

Group type: EXPERIMENTAL
Intervention: Fully automated Web-based program (ANODE)
Number of subjects: 120

Group type: COMPARATOR
Intervention: General nutritional advice (Control)
Number of subjects: 120
Study: 26159382

Group type: EXPERIMENTAL
Intervention: etch‐and‐rinse+moist dentin (ERm)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: etch‐and‐rinse+dry dentin (ERd)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: selective enamel etching (Set)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: self‐etch (SE)
Number of subjects: 39
Study: 24053756

Group type: EXPERIMENTAL
Intervention: Human advisor
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Automated interactive voice response advisor
Number of subjects: 218
Study: 22153015

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (6% HES 130/0.4) + high volume hemofiltration (HVHF) for 72 hours
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (6% hydroxyethyl starch (6% HES 130/0.4) for volume resuscitation)
Number of subjects: 108
Study: 19564761

Group type: EXPERIMENTAL
Intervention: Godelive Denys-Struyf (GDS) method
Number of subjects: 137

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 137
Study: 16859871

Group type: EXPERIMENTAL
Intervention: Chronic Disease Self‐management Program (CDSMP)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 320
Study: 15451131

Group type: EXPERIMENTAL
Intervention: Motivation to quit smoking
Number of subjects: 72
Study: 10706013

Group type: EXPERIMENTAL
Intervention: High levels of oestrogen
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: High levels of oestrogen and progesterone
Number of subjects: 25
Study: 9376207

Group type: EXPERIMENTAL
Intervention: Video supplement to informed consent
Number of subjects: 186

Group type: COMPARATOR
Intervention: Pamphlet review before discussion
Number of subjects: 186
Study: 1403040

Group type: EXPERIMENTAL
Intervention: CsA and etoposide
Number of subjects: 72
Study: 3904391

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 5507

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5507
Study: 3109340

Group type: EXPERIMENTAL
Intervention: dihydroergocristine
Number of subjects: 97

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 97
Study: 31162838

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel + carboplatin (nab-pac/carbo)
Number of subjects: 336

Group type: COMPARATOR
Intervention: nab-paclitaxel + gemcitabine (nab-pac/gem)
Number of subjects: 336
Study: 28833748

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation, cognitive behavioural therapy, and life review methods
Number of subjects: 6
Study: 27015660

Group type: EXPERIMENTAL
Intervention: Oral epigallocatechin-3-gallate (EGCG) treatment for 4 months
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 25773130

Group type: EXPERIMENTAL
Intervention: PCHMS (web-based personally controlled health management system)
Number of subjects: 747

Group type: COMPARATOR
Intervention: Control group (no PCHMS access)
Number of subjects: 747

Group type: EXPERIMENTAL
Intervention: PCHMS (web-based personally controlled health management system) among sexually active participants
Number of subjects: 747

Group type: COMPARATOR
Intervention: Control group (no PCHMS access) among sexually active participants
Number of subjects: 747
Study: 23110746

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 84
Study: 21134123

Group type: EXPERIMENTAL
Intervention: IV acetaminophen 1,000mg q6h
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: IV acetaminophen 650mg q4h
Number of subjects: 213

Group type: COMPARATOR
Intervention: Standard-of-care treatment
Number of subjects: 213
Study: 18249211

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/d
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Fenofibrate 200 mg/d
Number of subjects: 38
Study: 16780480

Group type: EXPERIMENTAL
Intervention: Topical 10% potassium hydroxide solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 20
Study: 14533336

Group type: EXPERIMENTAL
Intervention: Orthodontic Oral-B
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Oral-B Advantage 30
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Colgate Precision
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Aquafresh
Number of subjects: 46
Study: 10974801

Group type: EXPERIMENTAL
Intervention: Empathy-induction condition
Number of subjects: 205

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Empathy condition (women)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Child defendant gender (girl)
Number of subjects: 205
Study: 8649700

Group type: EXPERIMENTAL
Intervention: Weekly stripping of membranes
Number of subjects: 142

Group type: COMPARATOR
Intervention: Weekly gentle cervical examinations
Number of subjects: 142
Study: 1371197

Group type: EXPERIMENTAL
Intervention: Donor-specific transfusions (DST) and continuous intravenous cyclosporine (CsA) initiated 24 hr before transplantation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sequential therapy with Minnesota antilymphoblast globulin, azathioprine, and steroids with subsequent conversion to CsA (Control)
Number of subjects: 22
Study: 6378423

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 41
Study: 30773542

Group type: EXPERIMENTAL
Intervention: 4 °C RF‐APGD plasma jet treatment for 20 s
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 10 °C RF‐APGD plasma jet treatment for 20 s
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 20 °C RF‐APGD plasma jet treatment for 20 s
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 30 °C RF‐APGD plasma jet treatment for 20 s
Number of subjects: 52
Study: 29791672

Group type: EXPERIMENTAL
Intervention: Home care teaching program after radical prostatectomy (oral guidance, writing, and telephonic reinforcement)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 68
Study: 25730292

Group type: EXPERIMENTAL
Intervention: Topical liposomal lidocaine
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study: 24798104

Group type: EXPERIMENTAL
Intervention: Early sympathectomy (Group I) before Step 2 of the WHO analgesic ladder
Number of subjects: 109

Group type: COMPARATOR
Intervention: Standard analgesics according to the WHO ladder followed by sympathectomy as the fourth step (Group II)
Number of subjects: 109
Study: 21949243

Group type: EXPERIMENTAL
Intervention: Nordic walking (NW) exercise program, 60-min supervised sessions twice a week for 9 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 0
Study: 20597708

Group type: EXPERIMENTAL
Intervention: Anti-cholinergic load
Number of subjects: 112
Study: 18596959

Group type: EXPERIMENTAL
Intervention: Broccoli-rich diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pea-rich diet
Number of subjects: 0
Study: 15762938

Group type: EXPERIMENTAL
Intervention: Own perspective
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imagined in-group members' perspective
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imagined out-group members' perspective
Number of subjects: 0
Study: 11560538

Group type: EXPERIMENTAL
Intervention: 15 mg/d of sibutramine continuously throughout weeks 1-48 (n = 405)
Number of subjects: 1102

Group type: EXPERIMENTAL
Intervention: 15 mg/d of sibutramine intermittently during weeks 1-12, 19-30, and 37-48 (n = 395)
Number of subjects: 1102

Group type: COMPARATOR
Intervention: Placebo for weeks 5-48 (n = 201)
Number of subjects: 1102
Study: 9692129

Group type: EXPERIMENTAL
Intervention: Pleurodesis using a small percutaneous catheter (Cystofix catheter, CH10, 65 cm)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional large bore chest tube (CH24)
Number of subjects: 18
Study: 7799583

Group type: EXPERIMENTAL
Intervention: Conservative therapy
Number of subjects: 65
Study: 3391878

Group type: EXPERIMENTAL
Intervention: Erythromycin acistrate (EA) 500 mg tid for three days
Number of subjects: 61

Group type: COMPARATOR
Intervention: Erythromycin base (EB) enterotablets 500 mg tid for three days
Number of subjects: 61

Group type: COMPARATOR
Intervention: Erythromycin base (EB) enterocapsules 500 mg tid for three days
Number of subjects: 61

Group type: COMPARATOR
Intervention: Erythromycin stearate (ES) 500 mg tid for three days
Number of subjects: 61
Study: 31181242

Group type: EXPERIMENTAL
Intervention: Indirect resin composite veneers (Estenia)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Ceramic laminate veneers (IPS Empress Esthetic)
Number of subjects: 48
Study: 28726440

Group type: EXPERIMENTAL
Intervention: Strength at Home Men's Program (SAH‐M)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Enhanced Treatment as Usual (ETAU)
Number of subjects: 125
Study: 24763187

Group type: EXPERIMENTAL
Intervention: Veterans Physical Activity Questionnaire (VAPAQ)
Number of subjects: 55
Study: 23417658

Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Periovulatory phase
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Luteal phase
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Post-menses to ovulation
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Luteal phase among women with CD4 counts of <350 cells/µL
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Overall shedding frequency and magnitude
Number of subjects: 67
Study: 20878269

Group type: EXPERIMENTAL
Intervention: Tamoxifen and fenretinide
Number of subjects: 426

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 426
Study: 19406273

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 2322

Group type: COMPARATOR
Intervention: Objective markers of HF severity (ejection fraction, B-type natriuretic peptide, peak oxygen consumption)
Number of subjects: 2322

Group type: EXPERIMENTAL
Intervention: Multivariate analysis including age, gender, cardiopulmonary exercise testing duration, NYHA class, 6-minute walk distance, and peak respiratory exchange ratio
Number of subjects: 2322
Study: 17343007

Group type: EXPERIMENTAL
Intervention: Panax notoginseng saponins (PNS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (conventional treatment only)
Number of subjects: 50
Study: 15531495

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 11816898

Group type: EXPERIMENTAL
Intervention: Sucrose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 10193295

Group type: EXPERIMENTAL
Intervention: remifentanil with propofol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: remifentanil with isoflurane
Number of subjects: 12

Group type: COMPARATOR
Intervention: remifentanil (combined with either propofol or isoflurane)
Number of subjects: 12
Study: 7818448

Group type: EXPERIMENTAL
Intervention: Forced-air warming
Number of subjects: 8

Group type: COMPARATOR
Intervention: Shivering
Number of subjects: 8
Study: 3382461

Group type: COMPARATOR
Intervention: 2 mg cianopramine (acute administration)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 1, 2, and 3 mg cianopramine (chronic administration)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 3 mg cianopramine (superimposed single dose after chronic administration)
Number of subjects: 14
Study: 28643066

Group type: EXPERIMENTAL
Intervention: Surgical exosuit
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no exosuit)
Number of subjects: 20
Study: 27619026

Group type: EXPERIMENTAL
Intervention: Bipolar electrocautery (BC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Cold dissection (CD)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 25341739

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFA) in patients <50 years old
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFA) in patients >50 years old
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AADs)
Number of subjects: 0
Study: 23548855

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (440 mg of Mg oxide 3 times per week for 6 months)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (same administration protocol as Mg group)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation
Number of subjects: 54
Study: 21518840

Group type: EXPERIMENTAL
Intervention: 600 mg efavirenz with 600 mg rifampin/day
Number of subjects: 11

Group type: COMPARATOR
Intervention: 600 mg efavirenz/day
Number of subjects: 11
Study: 19522323

Group type: EXPERIMENTAL
Intervention: Pictures of faces
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pictures of faces (own, friend's, unknown)
Number of subjects: 0
Study: 16723928

Group type: EXPERIMENTAL
Intervention: Nurse-led case management (Evercare)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 132
Study: 15610326

Group type: EXPERIMENTAL
Intervention: Computer-assisted, patient-centered intervention
Number of subjects: 886

Group type: COMPARATOR
Intervention: Control practices
Number of subjects: 886
Study: 11356387

Group type: EXPERIMENTAL
Intervention: Gamma-irradiation (192Ir)
Number of subjects: 29
Study: 8568310

Group type: EXPERIMENTAL
Intervention: US inactivated split-virus vaccine
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Russian live attenuated, cold-adapted vaccine
Number of subjects: 555
Study: 1369722

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (600 mg for 60 days)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 91023

Group type: EXPERIMENTAL
Intervention: A combination of 50 mg acarbose and 14.5 g guar gum
Number of subjects: 8

Group type: COMPARATOR
Intervention: Acarbose alone
Number of subjects: 8
Study: 30010808

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention for 24 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Health education control intervention
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention for participants attending ≥25% of scheduled visits
Number of subjects: 40
Study: 28657948

Group type: EXPERIMENTAL
Intervention: Hospital Readmission Reduction Program (2010-2014)
Number of subjects: 5122240

Group type: EXPERIMENTAL
Intervention: Hospital Readmission Reduction Program (2010-2012)
Number of subjects: 5122240
Study: 25748698

Group type: EXPERIMENTAL
Intervention: hANP + DA (1-3 μg·kg·min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: hANP + furosemide (10-30 mg injection)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 24812742

Group type: EXPERIMENTAL
Intervention: Edgewise brackets without deep bite
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alexander brackets
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Edgewise brackets with deep bite
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alexander brackets with deep bite
Number of subjects: 40
Study: 22737876

Group type: EXPERIMENTAL
Intervention: Compound betamethasone injection 1 ml and benzathine penicillin 1 200 000 U, deeply injected into muscles on hips, one time.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Desloratadine 5 mg orally once a day and amoxicillin capsules 0.5 mg orally three times a day, taken for one week.
Number of subjects: 60